The new medication offers hope to patients grappling with the early stages of this relentless memory ... drug after ...

University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA™ (donanemab), a Food and Drug ...

It was one of the most difficult rescue missions of all time, involving as many as 10,000 people, and now we know that rescuers gave the boys a drug ... the brain. Narrator: So while FDA approval ...

Cognitive decline was assessed by a test that measures memory ... which include brain swelling and tiny bleeds. In 2021, the agency approved Biogen's amyloid-clearing drug aducanumab despite ...

This is the second diagnostic drug available for visualising beta amyloid on a PET scan of the brain. In 2012, the FDA approved Amyvid ... such as memory and judgment, that raise the possibility ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma ... in order to get the product approved and to patients faster. NeuroSTAT works by protecting and ...

So-called deep brain stimulation (DBS) has been approved by the US Food and Drug Administration for treating a range of conditions including Parkinson's disease, epilepsy and obsessive compulsive ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.